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Background: The major clinical dilemma managing acute rhinosinusitis (ARS) in pediatric 
population is distinguishing uncomplicated rhinosinusitis from a complicated bacterial ARS and 
orbital complications, the latter requiring antimicrobials and surgical intervention. However, 
factors associated with severe orbital complications and the optimum management strategy 
remains controversial. The objectives of this study were to characterize the clinical outcomes of 
children with orbital complications of ARS and to identify risk factors associated with disease 
severity. 
Methods: This retrospective cohort analysis evaluated the clinical outcomes of 61 children 
admitted for orbital complications between 1st January 2002 and 31st December 2017. Descriptive 
statistics were performed to examine the demographics and clinical findings. We compared groups 
using Mann–Whitney test for continuous variables and Chi-square for categorical variables. 
Results: Although two-thirds of children had received pre-hospital antibiotics, half of the cohort 
presented with post-septal orbital complications. While 83% of isolates obtained from the same 
patients were susceptible to the pre-hospital antibiotics given, the majority of those who received 
pre-hospital antibiotics nevertheless required surgical intervention. We observed significant 
association between the age of presentation and disease severity. Children older than 5 years of 
age presented with more severe orbital complications despite pre-hospital antibiotics and were 
more likely to require surgical intervention (p<0.001). 
Conclusion: In this study, stage II/III orbital complications at presentation and older age were the 
most important determinants of medical treatment failure. Early referral to ENT should be 




Acute rhinosinusitis (ARS) is a common childhood illness characterized by inflammation of the 
nose and paranasal sinuses, which usually follows a viral infection or allergic rhinitis and can be 
complicated by bacterial infection.1,2 ARS is often a self-limiting illness and although rare, carries 
a potential risk of severe complications and fatal outcome.1,3 Orbital involvement is the most 
common complication of ARS in the pediatric population,4,5 usually emerging from the direct 
extension of infection, local thrombophlebitis and acute ethmoid sinusitis, which is exacerbated in 
children due to an immature immune system and developmental anatomy.6,7  
Chandler et al.8 defined the orbital septum as an anatomical landmark setting the boundaries 
between pre- and post-septal spaces, differentiating the first two stages of orbital inflammation. 
The spread of infection to the post-septal space carries a significant risk of complications such as 
permanent visual loss, cerebral abscess and cavernous sinus thrombosis as well as adverse 
outcomes, i.e. prolonged hospitalization and antibiotic therapy, and the requirement for surgical 
intervention.6,9,10 Chandler has classified orbital complications into five stages based on disease 
severity, which is still being used today to establish treatment response and prognosis.  
The diagnosis of post-septal orbital complications is often difficult based on clinical examination; 
yet, early recognition and appropriate treatment are the only means by which to achieve a 
successful outcome in the pediatric population.5,11-14 The management of ARS in children remains 
a controversial and emerging subject.1,15 There is considerable variability between published 
literature in terms of the population at risk of severe orbital complications4,16-18, the need for 
imaging studies19 and indication for surgical intervention,20,21 thus, the optimum management 
strategy remains controversial.  
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This study aimed to describe 15-years of experience managing orbital complications of ARS in 
the pediatric population, to explain the real-life success of different management strategies and to 
identify risk factors associated with disease severity. 
 
Materials and Methods 
Study design and population 
A retrospective cross-sectional study was conducted between 1st January 2002 and 31st December 
2017. During this period, all children who were admitted to hospital with orbital complications of 
ARS under the care of otorhinolaryngology and maxillofacial surgical team were included in this 
study. Diagnosis of ARS was made based on the European Position Paper on Rhinosinusitis and 
Nasal Polyps (EPOS 2012) criteria.3 Orbital complications were categorized according to the 
Chandler classification; Stage I: inflammatory edema and pre-septal cellulitis, Stage II: orbital 
cellulitis, Stage III: subperiosteal abscess (SPOA), Stage IV: orbital abscess and Stage V: 
cavernous sinus thrombosis. For those patients with post-septal orbital complications (Stage 2 or 
greater) final classification was done after obtaining CT results.   
 
Data collection 
Patient demographics, length of hospital stay, previous antimicrobial therapy and clinical data 
including presenting symptoms, physical examination (eye, nose and throat/ENT specialist, 
ophthalmology and neurology), radiology findings and details of medical and surgical treatment 
were extracted from the medical records. Patient samples submitted for microbiology evaluation 
were identified and detailed microbiology data were retrieved from the laboratory database.  
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Clinical and radiological examination  
All patients were examined by an ENT specialist to confirm the diagnosis of ARS at the time of 
admission. Characteristics of sinonasal secretion were visually evaluated, and pus samples 
collected from all patients were sent for culture. Subsequently, all patients underwent 
ophthalmology and neurology examinations to clinically ascertain orbital complications. Patients 
with an abnormality found in either examination underwent further evaluation with computer 
tomography (CT). CT imaging was also performed in patients where the ophthalmology 
examination was inconclusive and in those who were non-responsive to medical treatment.  
 
Sampling and microbiology 
All patients had sinonasal aspiration sampling as a standard procedure prior to antibiotic treatment. 
Sinonasal aspiration involves endoscopic guided sampling of the middle meatus as described by 
Vogan JC et al.22 This technique has been shown to accurately identify the predominant bacterial 
pathogens with 90% culture correlation. Antral puncture is a painful procedure, and it is not 
recommended in children, except in specific occasions. In patients who underwent surgery, sinus 
secretions and pus sample from the drained abscess were also obtained and sent for microbiology 
evaluation. Routine microbiology procedures were used to identify pathogens involved; Gram 
stain, aerobic and anaerobic cultures and antibiotic susceptibility testing.  
 
Surgical treatment 
Patients who had visual impairment at the time of admission and failure of medical treatment 
warranted surgical intervention. Failure of medical treatment was defined as fever despite 48 hours 
of antibiotic treatment, progressive symptomatology and worsening inflammatory markers. 
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Endoscopic sinus surgery (ESS) was aimed at exposing the lamina papyracea (ethmoidal labyrinth) 
to identify possible dehiscence and evacuate the pathological tissue. In some cases, it was 
necessary to fracture or partially remove a part of lamina papyracea due to extensive dehiscence. 
Grade IV orbital complications were managed by a multidisciplinary team involving ENT, 
ophthalmology and infectious diseases/clinical microbiology. 
 
Statistical analyses 
Descriptive statistics were performed to examine the demographics and clinical findings. 
Categorical variables were summarized by frequencies and percentages. Continuous data were 
presented as counts or percentages (%). We compared groups using Mann–Whitney test for 
continuous variables and Chi-square test for categorical variables. To assess the role of pre-
hospital antimicrobial treatment in preventing orbital complications, we compared the use of 
antibiotic treatment before hospital admission with the stage of orbital complications and the 
clinical outcome. Clinical presentation and treatment outcomes were also compared between 
younger (≤5 years of age) and older children (>5 years of age). All analyses were performed using 
SPSS (version 19.0). 
 
Results 
Sociodemographic and clinical characteristics of children with ARS 
A total of 61 children who were hospitalized due to orbital complications following ARS were 
included in the study. Thirty-four patients were male (56%), F:M ratio was 1:1.3. The mean age 
was 5.4 years (7 months -14 years), 52.5% were less than 5 years of age. In total, 55 (90.1%) had 
documented fever, and 2 (3%) patients had visual impairment. At the time of admission, the 
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majority of patients (45/61; 74%) had Chandler grade I or II orbital complications. Fourteen 
patients (23%) had a SPOA (grade III), and two patients (3%) had an orbital abscess (grade IV). 
None of the patients had cavernous sinus thrombosis (stage V). CT imaging of paranasal sinuses 
was performed in 52/61 (85%) patients. Among those who underwent CT imaging, ethmoid 
sinuses were involved in all patients (52/52), and 46/52 (88%) had maxillary sinus involvement. 
Summary of sociodemographic and clinical characteristics are presented in Table 1. 
 
Treatment (medical and surgical) 
Because of visual impairment and limited ocular movement, two patients (3%) required immediate 
surgical intervention. The other patients (59/61; 97%) were initially managed medically with 
antibiotic treatment, and additional surgical treatment was indicated in 30/59 (50.8%) patients who 
were non-responsive to medical treatment. The most frequently used treatment combination, in 
90% of this cohort, was third-generation cephalosporin and metronidazole. All patients who failed 
to respond to medical treatment and warranted surgical intervention (30/59; 50.8%) had stage II 
or III orbital complications, whereas the majority of patients who responded to the medical 
treatment (29/59; 49%) had stage I orbital complication (25/29; 86%). In total, 32 patients 
underwent ESS, 87.5% of those were appropriately managed with surgical drainage whereas four 
patients required an additional ophthalmology intervention. All patients recovered well after 
treatment without long-term complications.  
 
Microbiology analysis 
In total, 93 samples were obtained; 61 sinonasal secretion samples from all patients and 32 tissue 
samples from those who underwent EES. The microbiology results are shown in Figure 2. Positive 
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bacterial growth has been found in 80% (74/93) samples: 72% (44/61) in sinonasal secretion 
samples and 94% (30/32) in tissue samples. In total, 71 patients had one isolate, two patients had 
two isolates, while one patient had three isolates. Multiple isolates were identified from the 
sinonasal secretions of three patients. The most frequently cultured bacteria were Streptococcus 
pyogenes (27/74; 36.5%) and Staphylococcus aureus (21/74; 28%) followed by Streptococcus 
pneumoniae (13/74; 18%), Haemophilus influenzae (7/74; 9.5%) and Moraxella catarrhalis (6/74; 
8%). Comparing microbiology growth in sinonasal secretions and tissue samples, isolates were 
matched in only 37.5% of patients. Three patients who were readmitted to the hospital had no 
microbial growth.  
 
Clinical outcome in association with pre-hospital antibiotics and age 
In total, 61% (37/61) of children received antibiotics before hospital admission. The most 
commonly prescribed antibiotics were amoxicillin, amoxicillin/clavulanic acid and third-
generation cephalosporins. Out of all, 75% of those who received pre-hospital antibiotics required 
surgical intervention. Overall, 83% of isolates obtained from these patients were susceptible to the 
pre-hospital antibiotics given. Pre-hospital antibiotic treatment had no significant impact on the 
severity of disease at presentation based on Chandler’s classification (p = 0.393) and management 
during hospitalization (p = 0.270). However, a significant association was observed between the 
age of presentation and disease severity (Table 2). The average hospital stay for all patients was 
8.8 days (range 3-18 days). The average hospital stay for the younger and older children were 7.9 
days and 10.2 days, respectively (p=0.06). At the time of admission, among those who received 
pre-hospital antibiotics, 28% of older children and none of the younger children presented with 
Chandler III or IV stage orbital complications (p<0.001). In addition, older children were more 
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likely to require surgical intervention compared to younger children, 72% and 25%, respectively 
(p<0.001). No recurrence was observed among older children, while 3 recurrences have occurred 
in the ≤5 years group. These three patients required multiple admissions, and subsequently 
required surgical intervention during the final hospitalization.  
 
Discussion  
In the current study, although two-thirds of children had received pre-hospital antibiotics, half of 
the cohort presented with post-septal orbital complications. While the isolates obtained from the 
same patients were susceptible to the pre-hospital antibiotics given, the majority of those who 
received pre-hospital antibiotics nevertheless required surgical intervention.  
 
Although hematogenous dissemination through infected thrombo-emboli or local 
thrombophlebitis has been reported as pathogenic mechanisms in the development of orbital 
complications, dehiscence of lamina papyracea has been indicated to play an important part in 
disease progression.8 During sinusitis, ethmoid inflammation may jeopardize the integrity of 
lamina papyracea, causing infection to progress further into the orbit.5,7,23 Supporting this 
pathogenic mechanism, histopathology evidence of lamina papyracea osteitis has been observed 
in children with SPOA.24 Pyogenic ethmoid osteitis could then lead to sequestrum formation 
resulting in vascular obliteration, local ischemia and bone necrosis.23 Accordingly, due to the 
insufficient blood supply to these avascular areas, the penetration of antibiotics and inflammatory 
cells may decrease. In this study, half of the cohort, the majority with stage I orbital complication, 
responded well to the intravenous antibiotics. In contrast, the other half, all with stage II or III 
complications, failed to improve with intravenous antibiotics although the isolates were found to 
 11 
be susceptible to the antibiotics given. This supports the hypothesis that bone involvement and 
dehiscence, likely decreased antibiotic penetration to the affected areas may be the principal cause 
of treatment failure.   
 
Several studies describe that a subset of patients with SPOA can successfully be treated with 
antibiotics;20,21,25 however, it is unclear which patients can be suitable for medical management.26 
In a prospective study of patients less than 9 years of age with small and medial SPOA, 93% cure 
rate was reported without surgery.20 On the other hand,  a retrospective study of patients with 
SPOA showed a considerably lower success of medical treatment; only 26% of the patients 
recovered without surgery.25 The response rate to medical treatment varies in all available studies. 
In this cohort, all patients with SPOA failed to improve on medical treatment and warranted ESS 
for evacuation and removal of the pathological process. In contrast to the perception that orbital 
complications of ARS are treated more conservatively today than in the past, Capra et al. has 
shown that surgical rates nearly doubled from 10.8% in 2000 to 19.5% in 2009 in the older 
children. 27  There is likely a shift towards surgical intervention especially in the older age group. 
 
Furthermore, in the literature there is conflicting evidence in regard to age being a significant 
determinant in the development of orbital complications. Different treatment protocols have been 
proposed for younger and older children,4,16-18 although some studies have demonstrated no 
significant difference in clinical presentation and clinical outcome based on age.21,25 In this study, 
children older than 5 years of age were significantly more likely to present with stage III or IV 
orbital complications despite pre-hospital antibiotics and more likely to require surgical 
intervention. In comparison, the majority of younger children who received pre-admission 
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antibiotics presented with stage I complications and were more likely to improve with in-hospital 
antibiotic treatment. Our findings support some available evidence that the infections in older 
children are more complicated at presentation regardless of pre-hospital antibiotics and younger 
children with stage I complications could be managed medically.17,18,20  These results are also in 
agreement with recently published studies. According to a population based study in the United 
States, older children with orbital complications of ARS were more likely to have been treated 
surgically. 27 In a recent study, toddlers (<2 years of age) were shown to have milder disease and 
had better outcomes without surgical intervention. 28  
 
The most common microorganism responsible for complicated ethmoiditis in the pediatric 
population is S. aureus, followed by Streptococcus spp.6,29 In the current study, the most frequently 
cultured bacteria were Streptococcus spp. and S. aureus. Compared with available studies, S. 
pneumoniae had a very high incidence rate in this cohort, which may be due to the pneumococcal 
vaccine not being part of the routine vaccination program in Serbia whereas H. influenzae was 
cultured in a small percentage of patients reflecting the H. influenzae serotype b vaccine coverage 
in the population.30 Additionally, in this study, microbiology concordance between the sinonasal 
secretions and tissue samples was poor, isolates were matched in only 37.5% cases. This 
emphasizes the importance of obtaining sterile samples during nasal sampling, as the nasal cavity 
contains a diversity of bacteria which do not usually originate from the sinuses. On the other side, 
the most reliable sample was a tissue sample as we confirmed bacterial presence in 94% tissue 
samples, while significantly less in sinonasal secretions (72%) (p< 0.001).  
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Contrast-enhanced CT has been recognized as the imaging study of choice in patients with a 
suspicion of orbital involvement. However, there is some controversy as to whether CT scan can 
distinguish an abscess collection from an inflammatory phlegmatous process.31 On the other hand, 
diffusion-weighted magnetic resonance imaging (MRI) is a more sensitive imaging modality 
which has recently gained attention as a tool to identify orbital abscess and describe intracranial 
complications.32,33 In this study, CT imaging was indicated in the majority of patients who had 
failed medical treatment to ascertain the next steps in the management of these patients. Imaging 
could help clinicians to assess the requirement for surgical drainage in patients with visual 
impairment or who are non-responsive to medical treatment.  
 
The significance of the present study is that we provide 15-years of real-life clinical experience of 
managing orbital complications of ARS in the pediatric population. There are some limitations. 
The study is based on observational data and due to its retrospective nature, some relevant 
information might have been missed during data collection. Additionally, likely reflecting the real-
life setting, we did not have an absolute strict criterion for treatment failure which was defined as 
not improving following 48h treatment, worsening inflammatory markers and/or clinical 
deterioration. Although our case series is unique to incorporate clinical, microbiology and surgical 
information, sample size remains limited. 
 
In conclusion, orbital complications of acute sinusitis remain a persisting problem in pediatric 
otorhinolaryngology. In this study, the most important determinants of antibiotic treatment failure 
were stage II or III orbital complications at presentation and older age (>5 years of age). Early 
referral to ENT should be considered for children >5 years with ARS as they present with worse 
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orbital complications despite pre-hospital antibiotic therapy. All isolates obtained were susceptible 
to the antibiotics given pre-admission and during the hospital stay, supporting the hypothesis that 
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Figure 1. Bacterial species isolated from the sinuses of children with ARS  
  
 17 
Table 1. Sociodemographic and clinical characteristics of children with ARS 
Variable N (%) 
(n=61) 
Age (years) 5.4 (7 months – 14 years) 
Sex  
Female 27 (36) 
Male 34 (56) 
High fever 55 (90) 

























Pre-admission antibiotics 37 (61) 
Failure of medical treatment 30 (51) 
Surgical treatment 32 (52) 




















Chandler stage III and IV at 
presentation   
0 (0) 8 (28) <0.001* 
Requirement for surgery 10 (25) 22 (72) <0.001* 
Average hospital stay (days)  7.9±2.8 10.2±2.1 0.06** 
* According to Chi-square test, p<0.05 





Figure 1. Bacterial species isolated from sinuses of children with ARS 
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